INMUNE BIO INC. Foreign Currency Transaction Gain (Loss), before Tax
INMUNE BIO INC. (INMB) reported Foreign Currency Transaction Gain (Loss), before Tax of $130.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2024-05-09
- INMUNE BIO INC. foreign currency transaction gain (loss), before tax for the quarter ending 2024-03-31 was $130.00K.
- INMUNE BIO INC. foreign currency transaction gain (loss), before tax for the quarter ending 2023-03-31 was -$9.00K.
- INMUNE BIO INC. foreign currency transaction gain (loss), before tax for fiscal 2023 was $100.00K, a 85.71% decline from fiscal 2022.
- INMUNE BIO INC. foreign currency transaction gain (loss), before tax for fiscal 2022 was $700.00K.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|---|
| 2024-03-31 | $130.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $100.00K 10-K · filed 2024-03-28 | |
| 2023-03-31 | -$9.00K 10-Q · filed 2024-05-09 | |
| 2022-12-31 | $700.00K 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |